title: Durable Response to Tyrosine Kinase Inhibitor Therapy in a Lung Cancer Patient Harboring Epidermal Growth Factor Receptor Tandem Kinase Domain Duplication.
authors.affiliation: *Department of Medicine, University of Washington, Seattle, Washington; and †Department of Laboratory Medicine, University of Washington, Seattle.
authors.forename: Christina S
authors.initials: CS
authors.lastname: Baik
authors.forename: David
authors.initials: D
authors.lastname: Wu
authors.forename: Christina
authors.initials: C
authors.lastname: Smith
authors.forename: Renato G
authors.initials: RG
authors.lastname: Martins
authors.forename: Colin C
authors.initials: CC
authors.lastname: Pritchard
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D017434:Protein Structure, Tertiary
chemical_list: D047428:Protein Kinase Inhibitors; C512478:EGFR protein, human; D066246:ErbB Receptors